Streetbeat News

Price Targets

BIIB

Wedbush analyst Laura Chico has reiterated a Neutral rating on Biogen (NASDAQ:BIIB) and maintained a $263 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:40 am

RBBN

JMP Securities analyst Erik Suppiger reiterated a Market Outperform rating on Ribbon Comms (NASDAQ:RBBN) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:39 am

SPRB

Oppenheimer analyst Hartaj Singh reiterated an Outperform rating on Spruce Biosciences (NASDAQ:SPRB) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:39 am

BPMC

JMP Securities analyst Reni Benjamin reiterates a Market Outperform rating on Blueprint Medicines (NASDAQ:BPMC) and maintains a $114 price target.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:37 am

WTW

BMO Capital analyst Michael Zaremski maintains a Market Perform rating on Willis Towers Watson (NASDAQ:WTW) and lowers the price target from $260 to $230.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:36 am

SNOW

Wells Fargo analyst Michael Turrin maintains an Overweight rating on Snowflake (NYSE:SNOW) and raises the price target from $170 to $200.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:35 am

BPMC

Wells Fargo analyst Derek Archila maintains an Equal-Weight rating on Blueprint Medicines (NASDAQ:BPMC) and raises the price target from $47 to $48.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 11:35 am

IMVT

Credit Suisse analyst Tiago Fauth reiterated an Underperform rating on Immunovant (NASDAQ:IMVT) and maintained a $4 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:34 am

ZM

Credit Suisse analyst Fred Lee reiterated a Neutral rating on Zoom Video Communications (NASDAQ:ZM) and maintained an $83 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:32 am

BIG

Credit Suisse analyst Karen Short maintains an Underperform rating on Big Lots (NYSE:BIG) and lowers the price target from $13 to $7.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 11:31 am